Betul A. Hatipoglu MD
Diabetes, Lipid Metabolism, Thyroid
Professor of Medicine CWRU/University Hospitals
Join to View Full Profile
11100 Euclid AveCleveland, OH 44106
Phone+1 216-844-3142
Fax+1 216-844-3120
Dr. Hatipoglu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Betul Hatipoglu is the Director for diabetes and obesity center and an endocrinologist in Cleveland, OH and is affiliated with University Hospitals. She received her medical degree from Istanbul University Faculty of Medicine and has been in practice 27 years. She specializes in diabetes, lipid metabolism, and thyroid and is experienced in prolactinoma, islet cell transplant surgery, and type 1 diabetes mellitus.
Education & Training
University of Illinois College of Medicine at ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 1997 - 1999
Istanbul University FomClass of 1992, MD
Michael Reese Hospital and Medical CenterResidency, Internal Medicine
Certifications & Licensure
OH State Medical License 2008 - 2026
IL State Medical License 1993 - 2011
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- The Impact of Combined Mindfulness-Based Interventions and Nutritional Counseling on Physician Burnout Start of enrollment: 2019 Dec 20
Publications & Presentations
PubMed
- Diabetes and Lipids: A Review and Update on Lipid Biomarkers and Cardiovascular Risk.Yumiko Tsushima, Betul Hatipoglu
Endocrine Practice. 2025-03-28 - A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.Yogish C Kudva, Dan Raghinaru, John W Lum, Timothy E Graham, David Liljenquist
The New England Journal of Medicine. 2025-03-19 - Trending Modalities in Type 2 Diabetes Prevention.Erika L Lundgrin, Betul Hatipoglu
The Journal of Clinical Endocrinology and Metabolism. 2025-02-25
Press Mentions
New Diabetes Treatment Delays Onset of Type 1 Diabetes; UH Treats First NE Ohio PatientDecember 1st, 2024- Senseonics Announces a Collaboration with the University Hospitals Accountable Care Organization (UHACO) in Cleveland, OhioSeptember 13th, 2021
Health Watch: Living with Type 1 DiabetesJanuary 10th, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
